SCHEDULE 13G/A 0001085146-25-004384 0001716774 XXXXXXXX LIVE 1 Common Stock, par value $0.0001 per share 12/31/2025 0001280776 IMMUNIC, INC. 4525EP101 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK NY 10036 Rule 13d-1(b) Aberdeen Group plc X0 0 8243941 0 8243941 8243941 N 6.85 HC abrdn Inc. X1 0 8243941 0 8243941 8243941 N 6.85 CO IA IMMUNIC, INC. 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, NEW YORK 10036 Aberdeen Group plc abrdn Inc. Aberdeen Group plc: 1 George Street Edinburgh, United Kingdom EH2 2LL abrdn Inc. 1900 Market Street Suite 200. Philadelphia, PA 19103 Aberdeen Group plc - UNITED KINGDOM abrdn Inc. - UNITED STATES N HC 8,243,941 6.85 Aberdeen Group plc - 0 abrdn Inc. - 0 Aberdeen Group plc - 8,243,941 abrdn Inc. - 8,243,941 Aberdeen Group plc - 0 abrdn Inc. - 0 Aberdeen Group plc - 8,243,941 abrdn Inc. - 8,243,941 Y Y N See Exhibit Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Aberdeen Group plc abrdn Holdings Limited abrdn Inc. Aberdeen Group plc is the parent company. abrdn Holdings Limited is the intermediate holding company for abrdn Inc. abrdn Inc. beneficially owns on behalf of our underlying clients 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Aberdeen Group plc F.Osei 12/31/2025 abrdn Inc. F.Osei 12/31/2025